DTI-015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTI-015, covering 2018-10-31 to 2018-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas [Phase 1, Phase 2]